1. Bosl, G., Motzer, R.J. (1997) Testicular germ-cell cancer. N Eng J Med, 337: 242–54.
2. Parkin, D.M., Whelan, S.L., Ferlay, J., Storm, H. (2009) Cancer Incidence in Five Continents, Vol I to VIII .IARC Cancerbase No. 7, Lyon.
3. Wu, X., Groves, F.D., McLaughlin, C.C., Jemal, A., Martin, J., Chen, V.W. (2005) Cancer incidence patterns among adolescents and young adults in the United States. Cancer Causes Control 16: 309–
20.
4. Stone, J.M., Sandeman, T.F., Ironside, P., Cruickshank, D.G., Mathews, J.P. (1992) Timetrends in accuracy of classification of testicular tumours, with clinical and epidemiological implications. Br J Cancer, 66: 396–401.
5. Jemal, A., Siegel, R., Ward, E., et al. (2009) Cancer Statistics, 2009. CA Cancer J Clin, 59(4):225-49.
6. Huyghe, E., Matsuda, T., Thonneau, P. (2003) Increasing incidence of testicular cancer worldwide: a review. J Urol, 170(1):5-11.
7. Chia, V.M., Quraishi, S.M., Devesa, S.F., Purdue, M.P., Cook, M.B., McGlynn, K.A. (2010) International Trends in the Incidence of Testicular Cancer, 1973-2002, Cancer Epidemiol Biomarkers Prev., 19; 1151.
8. Bray, F., Richiardi, L., Ekbom, A., Pukkala, E., Cununkova, M., Moller, H. (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer, 118: 3099–111.
9. Møller, H., Prener, A., Skakkebaek, N.E. (1996) Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy and genital malformations: case-control studies in Denmark. Cancer Causes Control, 7(2):264-74.
10. Dieckmann, K.P., Pichlmeier, U. (2004) Clinical epidemiology of testicular germ cell tumors World Journal of Urology, Volume 22, Number 1, 2-14.
11. Moller, H., Cortes, D., Engholm, G., Thorup, J. (1998) Risk of testicular cancer with cryptorchidism and with testicular biopsy:
cohort study, BMJ 317:729.
12. Klein, E.A. (1993) Tumour markers in testis cancer. Urol Clin North Am, 20(1):67-73.
13. Germa-Lluch, J.R., Garcia del Muro, X., Maroto, P., et al. Spanish Germ-Cell Cancer Group (2002) Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol, 42(6):553-62.
14. Javadpour, N. (1980) The role of biologic markers in testicular cancer. Cancer, 45(7Suppl):1755-61.
15. Albers P., Albrecht, W., Algaba, F., Bokemeyer, C., Cohn-Cedermark, G., Fizazi, K.,Horwich, A., Laguna, M.P. (2011) Guidelines on Testicular Cancer, European Association of Urology.
16. International Union against Cancer, 2002.
17. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers.
International Germ Cell Cancer Collaborative Group, J Clin Oncol.
1997 Feb;15(2):594-603.
18. Krege, S., Beyer, J., Souchon, R. et al. (2008) European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part I. Eur Urol 2008 53: 497-513.
19. Krege, S., Beyer, J., Souchon, R. et al. (2008) European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol 2008 53: 497-513.
20. Lindhoff-Last, E., Luxembourg, B.: Evidence-based indications for thrombophilia screening. Vasa 2008;37:19-30.
21. Marik, P.E., Plante, L.A.: Venous thromboembolic disease and pregnancy. N Engl J Med 2008;359:2025-2033.
22. Piccioli, A., Lensing, A.W., Prins, M.H., Falanga, A., Scannapieco, G.L., Leran, M., Cigolini, M., Ambrosio, G.B., Monreal, M., Girolami, A., Prandoni, P.: Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost 2004;2:884-889.
23. Kearon, C.: Natural history of venous thromboembolism. Circulation 2003;107:I22-I30.
24. Carrier, M., Le Gal, G., Wells, P.S., Fergusson, D., Ramsay, T., Rodger, M.A.: Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 2008;149:323-333.
25. White, R.H.: The epidemiology of venous thromboembolism.
Circulation 2003;107:I4-I8.
26. Schoepf, U.J., Holzknecht, N., Helmberger, T.K., Crispin, A., Hong, C., Becker, C.R., Reiser, M.F.: Subsegmental pulmonary emboli:
improved detection with thincollimation multi-detector row spiral CT.
Radiology 2002;222:483-490.
27. Pratt, 1954.
28. Collins, R., Burch, J., Cranny, G., Aguiar-Ibanez, R., Craig, D., Wright, K., Berry, E., Gough, M., Kleijnen, J., Westwood, M.: Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. Bmj 2007;334(7606):1257.
29. Bostrom, A., Karacagil, S., Lofberg, A.M., Ljungman, C., Nyman, R., Logason, K., Hellberg, A.: Selection of patients with lower limb arterial occlusive disease for endovascular treatment of the iliac arteries with duplex scanning. Vasc Surg 2001;35(6):437-42.
30. Rothwell, P.M., Coull, A.J., Silver, L.E., Fairhead, J.F., Giles, M.F., Lovelock, C.E., Redgrave, J.N., Bull, L.M., Welch, S.J., Cuthbertson, F.C., Binney, L.E., Gutnikov, S.A., Anslow, P., Banning, A.P., Mant, D., Mehta, Z.; Oxford Vascular Study.
Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories, Lancet. 2005 Nov 19;366(9499):1773-83.
31. Halter, G., Orend, K.H., Sunder-Plassmann, L. Chirurg. 2003 Dec;74(12):1118-27.
32. Alfke, H., Geks, J., Wagner, H.J. Chirurg. 2003 Dec;74(12):1110-7.
Epub 2003 Oct 22.
33. Trousseau, A. (1865) Phlegmasia alba dolens. Clinique Medicale de l'Hotel-Dieu 1865; 3:654-712.
34. Rickles, F.R., Levine, M.N. (2001) Epidemiology of thrombosis in cancer. Acta Haematol., 106(1-2):6-12.
35. Monreal, M., Fernandez-Llamazares, J., Perandreu, J., Urrutia, A., Sahuquillo, J.C., Contel, E. (1997) Occult cancer in patients with venous thromboembolism: which patients, which cancers. Thromb Haemost., 78(5):1316-8.
36. Monreal, M., Prandoni, P. (1999) Venous thromboembolism as first manifestation of cancer. Semin Thromb Hemost., 25(2):131-6.
37. Sørensen, H.T., Mellemkjaer, L., Steffensen, F.H., Olsen, J.H., Nielsen, G.L. (1998) The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med., 338(17):1169-73.
38. Baron, J.A., Gridley, G., Weiderpass, E., Nyrén, O., Linet, M., (1998) Venous thromboembolism and cancer. Lancet 351(9109):1077-80.
39. Prandoni, P., Lensing, A.W., Büller, H.R., Cogo, A., Prins, M.H., Cattelan, A.M., Cuppini, S., Noventa, F., ten Cate, J.W. (1992) Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med., 327(16):1128-33.
40. Monreal, M., Lafoz, E., Casals, A., Inaraja, L., Montserrat, E., Callejas, J.M., Martorell, A. (1991) Occult cancer in patients with deep venous thrombosis. A systematic approach. Cancer, 67(2):541-5.
41. Heit, J.A., Silverstein, M.D., Mohr, D.N., Petterson, T.M., O'Fallon, W.M., Melton, L.J. 3rd. (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.
Arch Intern Med., 160(6):809-15.
42. Blom, J.W., Doggen, C.J., Osanto, S., Rosendaal, F.R. (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA., 293(6):715-22.
43. Blom, J.W., Vanderschoot, J.P., Oostindiër, M.J., Osanto, S., van der Meer, F.J., Rosendaal, F.R. (2006) Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 4(3):529-35.
44. White, R.H., Chew, H.K., Zhou, H., Parikh-Patel, A., Harris, D., Harvey, D., Wun, T. (2005) Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med., 165(15):1782-7.
45. Sørensen, H.T., Mellemkjaer, L., Olsen, J.H., Baron, J.A. (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med., 343(25):1846-50.
46. Lee, A.Y. (2005) Management of thrombosis in cancer: primary prevention and secondary prophylaxis. Br J Haematol. 2005 Feb;128(3):291-302.
47. Chew, H.K., Wun, T., Harvey, D., Zhou, H., White, R.H. (2006) Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med., 166(4):458-64.
48. Khorana, A.A., Francis, C.W., Culakova, E., Kuderer, N.M., Lyman, G.H. (2007) Frequency, risk factors, and trends for venous
thromboembolism among hospitalized cancer patients. Cancer.
2007 Nov 15;110(10):2339-46.
49. Bredael, J.J., Vugrin, D., Whitmore, W.F. Jr. (1982) Autopsy findings in 154 patients with germ cell tumors of the testis. Cancer, 50(3):548-51.
50. Walsh-McMonagle, D., Green, D. (1997) Low-molecular-weight heparin in the management of Trousseau's syndrome. Cancer, 80(4):649-55.
51. Cantwell, B.M., Mannix, K.A., Roberts, J.T., Ghani, S.E., Harris, A.L. (1988) Thromboembolic events during combination chemotherapy for germ cell-malignancy. Lancet, 2(8619):1086-7.
52. Hall, M.R., Richards, M.A., Harper, P.G. (1988) Thromboembolic events during combination chemotherapy for germ cell malignancy.
Lancet, 2(8622):1259.
53. Hassan, B., Tung, K., Weeks, R., Mead, G.M. (1999) The management of inferior vena cava obstruction complicating metastatic germ cell tumors. Cancer, 85(4):912-8.
54. Weijl, N.I., Rutten, M.F., Zwinderman, A.H., Keizer, H.J., Nooy, M.A., Rosendaal, F.R., Cleton, F.J., Osanto, S. (2000) Thromboembolic events during chemotherapy for germ cell cancer:
a cohort study and review of the literature. J Clin Oncol. 2000 May;18(10):2169-78.
55. Jafri, M., Protheroe, A. (2008) Cisplatin-associated thrombosis.
Anticancer Drugs, 19(9):927-9.
56. Noble, S., Pasi, J. (2010) Epidemiology and pathophysiology of cancer-associated thrombosis. BrJ Cancer, 102 Suppl 1:S2-9.
57. Lyman, G.H. (2007) ASCO Clinical Practice Guidelines and Beyond. J Oncol Pract., 3(6):330-1.
58. Khorana, A.A., Francis, C.W., Culakova, E., Kuderer, N.M., Lyman, G.H. (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost, 5: 632–4.
59. Khorana, A.A., Kuderer, N.M., Culakova, E., Lyman, G.H., Francis, C.W. (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood, 111(10):4902-7.
60. Blom, J.W., Osanto, S., Rosendaal, F.R. (2004) The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost., 2(10):1760-5.
61. Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. 2009 Jun 16;53(24):2231-47.
62. Numico, G., Garrone, O., Dongiovanni, V., Silvestris, N., Colantonio, I., Di Costanzo, G., Granetto, C., Occelli, M., Fea, E., Heouaine, A., Gasco, M., Merlano, M. (2005) Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine. Cancer, 103(5):994-9.
63. Al-Batran, S.E., Hartmann, J.T., Probst, S., Schmalenberg, H., Hollerbach, S., Hofheinz, R., Rethwisch, V., Seipelt, G., Homann, N., Wilhelm, G., Schuch, G., Stoehlmacher, J., Derigs, H.G., Hegewisch-Becker, S., Grossmann, J., Pauligk, C., Atmaca, A., Bokemeyer, C., Knuth, A., Jäger, E.; Arbeitsgemeinschaft Internistische Onkologie (2008) Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol., 26(9):1435-42.
64. Starling, N., Rao, S., Cunningham, D., Iveson, T., Nicolson, M., Coxon, F., Middleton, G., Daniel, F., Oates, J., Norman, A.R. (2009) Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group. J Clin Oncol., 27(23):3786-93.
65. Moore, R.A., Adel, N., Riedel, E., Bhutani, M., Feldman, D.R., Tabbara, N.E., Soff, G., Parameswaran, R., Hassoun, H. (2011) High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. J Clin Oncol., 29(25):3466-73.
66. Piketty, A.C., Fléchon, A., Laplanche, A., Nouyrigat, E., Droz, J.P., Théodore, C., Fizazi, K. (2005) The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area.
Br J Cancer., 93(8):909-14.
67. Nuver, J., Lutke Holzik, M.F., van Zweeden, M., Hoekstra, H.J., Meijer, C., Suurmeijer, A.J., Groen, H.J., Hofstra, R.M., Sluiter, W.J., Groen, H., Sleijfer, D.T., Gietema, J.A. (2005) Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patients. Pharmacogenet Genomics., 15(6):399-405.
68. Lemmers, N.W., Gels, M.E., Sleijfer, D.T., Plukker, J.T., van der Graaf, W.T., de Langen, Z.J., Droste, J.H., Koops, H.S., Hoekstra, H.J. (1996) Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy.
J Clin Oncol. 1996 Nov;14(11):2916-22.
69. Verso, M., Agnelli, G. (2003) Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol., 21(19):3665-75.
70. Khorana, A.A. (2009) Cancer and thrombosis: implications of published guidelines for clinical practice. Ann Oncol., 20(10):1619-30. Epub 2009 Jun 26.
71. Lyman, G.H. (2007) ASCO Clinical Practice Guidelines and Beyond. J Oncol Pract., 3(6):330-1.
72. Streiff, M.B. (2010) The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients. Thromb Res., 125 Suppl 2:S128-33.
73. Van Strijen, M.J., De Monye, W., Kieft, G.J., Pattynama, P.M., Prins, M.H., Huisman, M.V. (2005) Accuracy of single-detector spiral CT in the diagnosis of pulmonary embolism: a prospective multicenter cohort study of consecutive patients with abnormal perfusion scintigraphy. J Thromb Haemost. 2005 Jan;3(1):17-25.
74. Blanke, P., Apfaltrer, P., Ebersberger, U., Schindler, A., Langer, M., Schoepf, U.J. (2012) CT detection of pulmonary embolism and aortic dissection. Cardiol Clin. 2012 Feb;30(1):103-16. doi:
10.1016/j.ccl.2011.11.006. Epub 2011 Dec 12.
75. Thomas, S.M., Goodacre, S.W., Sampson, F.C., van Beek, E.J.
(2008) Diagnostic value of CT for deep vein thrombosis: results of a systematic review and metaanalysis. Clin Radiol 2008;63:299-304.
76. AWMF-S3-Leitlinie: „Prophylaxe der venösen Thromboembolie (VTE)“ (2009), ttp://www.awmf.org/uploads/tx_szleitlinien/003-001l_S3_Thromboembolie-Prophylaxe_2010.pdf
77. Ay, C., Dunkler, D., Marosi, C., Chiriac, A.L., Vormittag, R., Simanek, R., Quehenberger, P., Zielinski, C., Pabinger, I. (2010) Prediction of venous thromboembolism in cancer patients. Blood.
2010 Dec 9;116(24):5377-82. doi: 10.1182/blood-2010-02-270116.
Epub 2010 Sep 9.